In recent years, drug advertising in India has become a platform for false drug claims and to exaggerate drug efficacy; no drugs may support or proclaim to stop or curative or may communicate to the intended user there of any concept that it should prevent or curative a single or more of the illness or disorders listed in Schedule J and advertise medications that are for conditions which are regulated under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.This study examined the advertisements on medicines and treatments in some Indian newspapers for their rationale, truth, and infringement of Indian laws.During this observational study, an analysis of advertisements appearing within the month of February 2023 in 05 newspapers comprising English, Kannada, and Malayalam was carried out to support the availability of the 2 legislations.A total 108 drug advertisements which could be a duplication of 35 individual advertisements were analyzed; showed that they were about sexual pleasance, diabetes, hair problems, eye problem, high pressure, piles, goiter, varicose vein, etc. 61 out of 108 (57%) advertisements violated the DMRA (Objectionable remedies) and provisions of Schedule J of Drugs and Cosmetics Act.Fraudulent therapies and medicines lacking evidence are being advertised, disregarding Schedule J of the Drugs and Cosmetics Act which prohibits claiming to cure
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: